Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

NanoStaph

Financiado

Force nanoscopy of staphylococcal biofilms

Staphylococcus aureus is a leading cause of hospital-acquired infections, which are often complicated by the ability of this pathogen to grow as biofilms on indwelling medical devices. Because biofilms protect the bacteria from ho... ver más

30/09/2021

UCLouvain

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

UNIVERSITE CATHOLIQUE DE LOUVAIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-09-30

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-ADG-2015: ERC Advanced Grant

I+D

Cerrada hace 9 años

0% 100%

2 Participantes

UCLouvain

2.48M€ | Lider

GMV AEROSPACE AND DEFENCE

536.16K€ | Participante

Proyectos interesantes

PID2019-104111RB-I00 RECUBRIMIENTOS DE HIDROGEL QUE CONTIENEN NANOPARTICULAS ANTI... 157K€ Cerrado

CTQ2017-84473-R CONTROL ESPACIO-TEMPORAL DE LA LIBERACION DE ANTIBIOTICOS DE... 163K€ Cerrado

NANO-PROTECT Antimicrobial nano-coatings for hospital textiles to prevent... 165K€ Cerrado

EIN2020-112327 NANOPARTICULAS PUNZANTES BASADAS EN CELULOSA COMO BACTERICID... 15K€ Cerrado

PLEC2022-009356 Nanoterapía disruptiva para combatir AMR por desagregación d... 273K€ Cerrado

PRE2020-093041 RECUBRIMIENTOS DE HIDROGEL QUE CONTIENEN NANOPARTICULAS ANTI... 99K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 64 meses Fecha Inicio: 2016-05-12
Fecha Fin: 2021-09-30

Líder del proyecto

UNIVERSITE CATHOLIQUE DE LOUVAIN

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto Staphylococcus aureus is a leading cause of hospital-acquired infections, which are often complicated by the ability of this pathogen to grow as biofilms on indwelling medical devices. Because biofilms protect the bacteria from host defenses and are resistant to many antibiotics, biofilm-related infections are difficult to fight and represent a tremendous burden on our healthcare system. Today, a true molecular understanding of the fundamental interactions driving staphylococcal adhesion and biofilm formation is lacking owing to the lack of high-resolution probing techniques. This knowledge would greatly contribute to the development of novel anti-adhesion therapies for combating biofilm infections. We recently established advanced atomic force microscopy (AFM) techniques for analyzing the nanoscale surface architecture and interactions of microbial cells, allowing us to elucidate key cellular functions. This multidisciplinary project aims at developing an innovative AFM-based force nanoscopy platform in biofilm research, enabling us to understand the molecular mechanisms of S. aureus adhesion in a way that was not possible before, and to optimize the use of anti-adhesion compounds capable to inhibit biofilm formation by this pathogen. NanoStaph will have strong scientific, societal and economical impacts. From the technical perspective, force nanoscopy will represent an unconventional methodology for the high throughput and high resolution characterization of adhesion forces in living cells, especially in bacterial pathogens. In microbiology, the results will radically transform our perception of the molecular bases of biofilm formation by S. aureus. In medicine, the project will provide a new screening method for the fast, label-free analysis of anti-adhesion compounds targeting S. aureus strains, including antibiotic-resistant clinical isolates that are notoriously difficult to treat, thus paving the way to the development of anti-adhesion therapies.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores